Chemotherapy in non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/6/suppl_1/S83/6679679/6-suppl_1-S83.pdf
Reference86 articles.
1. Future directions in the management of non-small cell lung cancer;Bunn;Lung Cancer,1993
2. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: A study of the Eastern Cooperative Oncology Group;Bonomi;J Clin Oncol,1989
3. Cisplatin (DDP) combined with teniposide (VM26) improves response and survival over VM26 alone in non-small cell lung cancer (NSCLC). A randomized trial of the EORTC Lung Cancer Cooperative Group;Giaccone;Proc Am Soc Clin Oncol,1993
4. Randomised study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicentre trial including 612 patients;Le Chevalier;J Clin Oncol,1994
5. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomised trial;Depierre;Ann Oncol,1994
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation;International Journal of Pharmaceutics;2024-03
2. Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer;Frontiers in Immunology;2022-06-02
3. Development and Validation of Segmentation Method for Lung Cancer Volumetry on Chest CT;Journal of Digital Imaging;2018-01-29
4. Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study;Practical Radiation Oncology;2015-07
5. Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARα receptors;Molecular Carcinogenesis;2013-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3